CCN2/connective tissue growth factor (CTGF) is a unique molecule that promotes both chondrocytic differentiation and proliferation through its matricellular interaction with a number of extracellular biomolecules. This apparently contradictory functional property of CCN2 suggests its certain role in basic cellular activities such as energy metabolism, which is required for both proliferation and differentiation. Comparative metabolomic analysis of costal chondrocytes isolated from wild-type and Ccn2-null mice revealed overall impaired metabolism in the latter. Among the numerous metabolites analyzed, stable reduction in the intracellular level of ATP, GTP, CTP or UTP was observed, indicating a profound role of CCN2 in energy metabolism.
Introduction
Endochondral ossification is a critical process that determines the skeletal size of vertebrates Takigawa, 2007, 2011; Takigawa, 2013) . This sophisticated process is initiated during the development of long bones, which begin as cartilage anlagen, and remains active until the cessation of body growth. Even after the completion of skeletal growth, endochondral ossification recurs upon bone injury and fracture as a central procedure to regenerate bone defects; and it thus is an indispensable biological process throughout life.
The central player of endochondral ossification is the growth-plate chondrocyte, the cell responsible for the growth of long bones and one that follows a characteristic pathway of differentiation. Chondrocytes differentiate from condensed mesenchyme and begin to produce cartilaginous extracellular matrix (ECM) components, such as type II collagen and aggrecan, to form and support the integrity of the cartilage anlagen.
These cells initially remain in a quiescent stage and are designated as resting chondrocytes. Subsequently, these resting chondrocytes begin to proliferate, causing the growth of the anlagen while forming a columnar alignment of themselves. After the proliferative stage, these cells undergo a maturation process. Next, chondrocytes near the bone-cartilage junction in the growth plate differentiate into hypertrophic chondrocytes, which cells induce matrix vesicle-mediated calcification, producing type X collagen and matrix metalloproteinase 13 (MMP-13). This calcifying hypertrophic layer of the growing cartilage is invaded by blood vessels and finally replaced by bone tissue Takigawa, 2007, 2011; Takigawa, 2013) .
In general, cell proliferation and differentiation are thought to be biologically incompatible events. Consistent with this notion, a significant number of extracellular 4 signaling factors that promote either proliferation or differentiation have been reported. For example, fibroblast growth factor 2 (FGF2) (Weksler et al., 1999) promotes the proliferation of growth-plate chondrocytes while inhibiting their differentiation.
Contrarily, parathyroid hormone (PTH) evidently enhance chondrocytic differentiation, whereas they exert no significant effect on cell proliferation (Takigawa et al., 1981) .
However surprisingly, CCN2 was re-discovered as a factor that could promote both cell proliferation and differentiation and even hypertrophy of chondrocytes throughout the process of endochondral ossification. Perbal and Takigawa, 2005) CCN2, also known as connective tissue growth factor (CTGF), is a member of the CCN family of secreted multi-functional proteins (Brigstock et al., 2003; Perbal, 2004; Perbal and Takigawa, 2005; Leask and Abraham, 2006; Jun and Lau, 2011) . Previous studies showed that the addition of exogenous CCN2 to cultured chondrocytes promoted the proliferation and enhanced their synthesis of proteoglycans concomitant with elevated expression of chondrocyte-associated genes. These data in vitro indicate that CCN2 indeed promotes the proliferation and differentiation of chondrocytes (Nakanishi et al., 1997 Nishida et al., 2000 Nishida et al., , 2002 . Moreover, in other previous studies in vivo, proliferative defect was indicated in chondrocytes in neonatal growth plates of Ccn2-null mice (Ivkovic et al., 2003; Kawaki et al., 2008) . In the same studies, it was also shown that Ccn2-deficient growth-plate cartilage exhibits defects in extracellular matrix formation. These in vivo data firmly support the in vitro finding that CCN2 is a promoter of cell proliferation and differentiation during endochondral ossification.
The mechanism by which CCN2 enhances these apparently incompatible events has remained unclear. However, considering that both of these activities require energy 5 consumption, it is evident that both cell proliferation and differentiation are supported by and under the control of the metabolic system providing energy. Thus, in this present study we aimed at examining the critical role of CCN2 in the energy metabolism of growth-plate chondrocytes.
Materials and Methods

Histochemical analysis
The CCN2-KO mice used in this study were previously described (Ivkovic et al., 2003) . Hind limbs removed at embryonic day (E) 18.5 or E19.5 were fixed with 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (pH 7.4) for 24 h. The samples were then decalcified with 10% EDTA for 3-7 days, depending on their age prior to embedment in paraffin. Preparation of thin sections and Alcian blue staining was performed as described previously (Kawaki et al., 2008) . Paraffin sections after staining were examined under a Microphoto FXA light microscope equipped with a DXM1200 digital camera (Nikon, Kawasaki, Japan). All animal experiments in this study were conducted according to the Guidelines for Animal Research of Okayama University and were approved by the animal committee.
Cell culture
Costal chondrocytes were isolated from rib cartilage of Ccn2-null mice and wildtype littermates at E18.5 or E19.5, following an established protocol as previously described (Kawaki et al., 2008; Hattori et al., 2010) . Briefly, after careful elimination of soft tissues by digestion with 0.05% trypsin for 5 min at 37°C, the cartilage was 6 digested with 3 mg/ml collagenase A (Roche, Basel, Switzerland) for 1.5h at 37°C to liberate the chondrocytes. These cells were then inoculated into 6-well multiplates containing Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and incubated at 37°C under 5% CO 2 in air. The isolated chondrocytes were utilized for experiments within 2 passages in culture. Occasionally, the cells were treated with recombinant human CCN2 for the desired time period.
Metabolome analysis
Extraction of total metabolites from murine chondrocytes was performed by the method recommended by Human Metabolome Technologies (Tsuruoka, Japan). The cells isolated from rib cage cartilage were inoculated into a 6-well multi-plate at a density of 3.6 × 10 5 cells/well and were cultured. At confluence, the cells were washed with 5% mannitol solution (Wako, Osaka, Japan) twice and then were scraped and transferred to a centrifuge tube after the addition of methanol containing 10 µM Internal Standard Solution (Human Metabolome Technologies). They were immediately frozen and stored at -80°C until metabolite extraction could be performed.
Prior to the analysis, these samples were mixed with chloroform and ultra pure water and centrifuged at 5,000×g for 5 min at 4°C. For removal of proteins, the sample was centrifugally passed through a filter (5 kDa, MILLIPORE, Billerica, MA). The filtrates were centrifuged and dissolved in 25 µl of ultra pure water. Then cationic and anionic metabolite analysis with a capillary electrophoresis time-of-flight mass spectrometer (CE-TOFMS) was performed (Agilent CE-TOFMS system, Agilent
Technologies Japan, Ltd., Tokyo, Japan). Cationic metabolites were analyzed by using were processed by using software (MasterHands ver.2.9.0.9, Keio Univ., Tokyo, Japan).
In this way, m/z value, migration time, and peak area level were obtained. The peak area level was converted into a relative area level per cell by the following expression:
Relative area level -objective peak area / (the area of an internal material × cell count)
As target materials, 108 substances including amino acids, organic acids, sugar phosphoric acids, and the nucleic acids were analyzed. The concentration of each material was calculated in reference to the concentration of the internal standard material (200 µM).
RNA extraction and real-time reverse-transcription polymerase chain reaction (RT-PCR) analysis
Total RNA was extracted and purified by using an RNeasy Mini Kit according to the manufacturer's instructions (Qiagen, Hilden, Germany) and was then reverse-transcribed to cDNA by use of avian myeloblastosis virus reverse transcriptase 
ATP quantification by bioluminescence assay
The intracellular ATP level was measured by use of an ATP bioluminescence assay kit (Roche), according to manufacturer's recommendations. Briefly, Ccn2-null and WT chondrocytes were initially inoculated at a density of 3.6-3.7 × 10 5 cells/well into 6-well multiplates. After reaching confluence, the cells were seeded at a density of 2 × 10 5 cells/well into 24-well multiplates and further cultured. At confluence, the chondrocytes were collected and suspended in 100 µl of phosphate-buffered saline (PBS). Next, 9 volumes of boiling hot 100 mM Tris-HCl containing 4 mM EDTA (pH7.75) was added to the cell suspension, and the cells were boiled for 2 min and thereafter centrifuged at 1,000 x g for 60 s. Fifty microliters of sample/standard was transferred to each well in a 96-well plate. Then, the luciferase reagent was added to the sample/standard, and the emitted light was measured with a luminometer FBS were seeded at a density of 1.0×10 6 cells/ well into 6-well plate for RNA extraction and at a density of 2.0×10 5 cells/ well into 24-well for ATP bioluminescence assay and were incubated at 37°C under 5% CO 2 in the air. After 24 hours, the cells were collected for subsequent analyses.
Microarray analysis
Comparative transcriptome analysis was performed by using a mouse Panorama
Micro Array (Sigma, St Louis, MO) according to the manufacturer's instruction. Total RNA was extracted from 8 individual mouse embryos from 4 different litters at an embryonic day described elsewhere and was mixed before being subjected to labeling.
Signals were captured and quantified by use of a GenePix 4000B (Molecular Devices, Sunnyvale, CA).
Evaluation of mitochondrial membrane potential
A mitochondrion-specific thiol-reactive fluorescent probe (Mito tracker ® RED CM-H 2 XRos, Invitrogen, Carlsbad, CA) was employed for the evaluation of the mitochondrial membrane potential. Ccn2-KO and wild-type chondrocytes were grown to subconfluence in 24-well multiplates and 4-well slide chambers, treated with 200 nM Mito tracker at 37℃ for 30 min, washed with PBS, and fixed in 3.7%
formaldehyde at 37 ℃ for 15 min. Thereafter, PBS containing 1 µg/ml of 4',6-diamidino-2-phenylindole (DAPI) was added for nuclear staining. Quantitative and qualitative evaluations of mitochondrial activity were conducted by using a high-content analyzing system (Cellomics TM ArrayScan ® VTL System, ThermoFisher SCIENTIFIC, Waltham, MA) and an automated microscope (BZ9000, Keyence, Osaka, Japan).
Statistical Analysis
The results obtained from quantitative experiments were reported as the mean values +/-standard deviation (SD). Statistical comparisons between the groups were performed by using Student's t-test. Unless otherwise specified, all experiments were repeated at least twice, and comparable results were obtained.
Results
Depressed biological activities observed in the cartilage of Ccn2-null mice
As found previously (Ivkovic et al., 2003; Kawaki et al., 2008) , growth 11 retardation and delayed chondrocyte differentiation were observed in the Ccn2-null mice (Fig. 1A) , which findings are in line with our hypothesis that CCN2 may support basic metabolism during cartilage development. First of all, in order to confirm these findings, we comparatively reevaluated the production of cartilaginous ECM in vivo, which is the most proper and critical characteristic of chondrocytes. As clearly observed in Fig. 1B , compared with that in the wild type tissue, the content of Alcian blue-stained sulfated proteoglycans was markedly reduced in the developing cartilage from the Ccn2-null mice. This result is entirely consistent with previous reports indicating impaired ECM synthesis in the cartilaginous tissues in Ccn2-null mice (Ivkovic et al., 2003) . Synthesizing proteoglylcans is a series of anabolic events that requires energy support. Considering that cell proliferation is also impaired in those cells, these findings collectively suggest depressed energy supply in Ccn2-null chondrocytes.
Metabolic profiles of Ccn2-null chondrocytes that represent a deficiency in basic energy supply system.
In the living body, a large part of energy is captured through the catabolic pathway, in which acetyl-coenzyme A (CoA) is central. Particularly, the low level of acetyl-CoA should be noted. The observed overall decrease in the levels of these glycolytic metabolites suggests a fundamental deficiency in the metabolic pathway for biological energy production in the Ccn2-null chondrocytes.
Intractable decrease in the intracellular ATP and other high-energy mononucleotides in Ccn2-null chondrocytes
We repeated the whole quantitative metabolome analysis twice and found remarkable variances in a number of metabolites between 2 experiments. In Fig. 3 , the results of 2 independent sets of experiments with independent animals are comparatively plotted. Obviously, a major part of metabolites were reproducibly decreased in the Ccn2-null choncrocytes (dots in the blue square); whereas no metabolites with a reproducible increase in these chondrocytes were noted (no dots in the red square). Several metabolites showed quite large variance between the 2 experiments. For example, the hypoxanthine level in Ccn2-null chondrocytes was less than that in the wild type in the first evaluation, whereas in the second evaluation, it was more than twice higher in the Ccn2-null cells. However, out of 100 metabolites, only 6 of them on the diagonal in Fig. 3 reproducibly yielded a stable reduction in the Ccn2-null chondrocytes. Interestingly, ATP was included among these 6 metabolites (the red dot in Fig. 3 ) and showed the second-largest reduction in Ccn2-null cells among 13 these metabolites. It should be also noted that the intracellular levels of other high-energy mononucleotides, i.e., GTP, CTP, and UTP, were also always decreased by Ccn2 deletion (Fig. 4A and B) . The fact that the relative ratio among the 4 mononucleotides was comparable between Ccn2-null and wild-type chondrocytes (Fig.   4A ) indicates that the mutual interchange system among these nucleotides was not affected by the Ccn2 deletion. Considering the stability and strength of the effect of the Ccn2 deletion on it, together with its having the highest intracellular level among the 4 nucleotides, ATP would supposedly be a critical metabolic target of CCN2 in chondrocytes.
Recovery of the intracellular ATP level in Ccn2-null chondrocytes by the addition of exogenous CCN2 in vitro
The results of metabolome analysis via CE-mass spectrometry clearly indicated the requirement of CCN2 for the maintenance of high cellular ATP levels. This finding was further confirmed by a different experimental strategy with a bioluminescence quantification of ATP activity. As exactly indicated by the metabolome analysis, the results of the ATP bioluminescence assay also showed that the ATP level in Ccn2-null chondrocytes was decreased by more than 50% in comparison with that in the wild-type ones (Fig. 5A ). Utilizing this experimental system, we tested if exogenous CCN2
could rescue the defect in ATP level caused by the Ccn2 deletion. We added human recombinant CCN2 to cultures of Ccn2-null and wild-type chondrocytes and evaluated its effect. This recombinant CCN2 was also used for our very recent study describing the cartilage regenerative effects of CCN2 derivatives and actually showed sufficient biological activities in vitro and in vivo (Abd El Kader et al., 2013) . As expected, the 14 intracellular ATP level in the Ccn2-null chondrocytes was recovered by the treatment with exogenous CCN2 for 48 h (Fig. 5B) , whereas it was not significantly by the treatment for 24 h. Of note, the addition of the same amount of CCN2 to the wild-type cultures appeared to increase the ATP level modestly in them as well. Considering that CCN2 enhances cell proliferation and ECM production, both energy-dependent processes, it is reasonable that CCN2 was capable of enhancing ATP synthesis in the chondrocytes.
Reduction of ATP level in human chondrocytic cells by transient silencing of CCN2
Since permanent Ccn2 deletion affects the differentiation of growth plate chondrocytes, cellular compositions along with the differentiation may differ between
Ccn2-null and wild type growth plates, which may affect metabolic profiles. In order to rule out this possibility, we utilized a human chondrocytic cell line, HCS-2/8, which is widely known to stably retain mature chondrocytic phenotype. By using a synthetic siRNA, CCN2 expression was transiently silenced in HCS-2/8 cells, and cellular ATP level was evaluated. As a result, cellular ATP level was significantly reduced in CCN2-silenced HCS-2/8 cells (Fig. 6) . Therefore, ATP reduction in CCN2-depleted chondrocytes is not due to the altered cellular composition, but is caused by individual cellular events.
Effect of Ccn2 depletion on the expression of various components of the metabolic machinery
Next, in order to identify genes that mediated the observed phenotypic changes upon Ccn2 deletion, we performed transcriptome analysis. RNA was extracted and 15 mixed from 8 individual Ccn2-null or wild-type mice from 3 different litters in order to minimize possible individual variation. Microarray analysis of these RNA mixtures showed that the long-term lack of CCN2 increased the expression level of several ribosomal protein genes, i.e., Rpl38, Rpl2, Rpl26 and Rpl35 (Fig. 7A) . Ccn3, which is another member of the CCN family, was also up-regulated in the Ccn2-null chondrocytes, as previously reported (Kawaki et al., 2008) . Contrarily, in addition to the genes encoding cartilaginous ECM components, such as type 9 procollagen and aggrecan, a few genes closely related to energy metabolism were repressed by Ccn2 deletion (Fig. 7B ). One such gene was Atp5l, encoding the ATP synthase subunit  in the ATP synthase complex, a critical mitochondrial molecular motor that supplies a major part of cellular ATP through the respiratory chain. In addition, the enolase 1 gene, encoding an enzyme built into the glycolytic pathway, was also found by microarray analysis to have been down-regulated.
Effect of Ccn2 depletion on mitochondrial activity and Eno1 expression in chondrocytes
Subsequently, since we found a possible defect in the mitochondrial energy production system through microarray analysis, we next evaluated the biological activity of mitochondria in Ccn2-null chondrocytes. Utilizing Mitotracker, which contained a mildly thiol-reactive chloromethyl moiety, we fluorescently labeled only the active mitochondria, in which oxidative phosphorylation occurred. As a result, active mitochondria were efficiently detected in both wild-type and Ccn2-null chondrocytes.
Although we observed stronger signals in chondrocytes from a few of the wild-type mouse embryos examined (Fig. 8A ), quantitative analysis of chondrocytes from several more animals revealed no significant difference in mitochondrial activity between wild-type and Ccn2-null chondrocytes (data not shown). These results suggest a limited involvement of the mitochondria in the observed ATP deficiency in Ccn2-null chondrocytes and a relatively minor role of the respiratory chain as a source of ATP in chondrocytes.
Attenuated glycolysis in Ccn2-null chondrocytes was also suggested by the data shown in Fig. 2 , in which case the involvement of the Eno1 gene was strongly suspected based on the data in Fig. 7 . In order to confirm the repression of the Eno1 gene in
Ccn2-null chondrocytes, we performed quantitative real-time RT-PCR analysis and obtained the expected results (Fig. 8B) . Therefore, these data strongly suggest that CCN2 regulated ATP production mainly through the anaerobic pathway, specifically targeting the enolase gene.
Discussion
Our present study clearly indicated that the intracellular ATP level was maintained at a higher level in chondrocytes in the presence of CCN2 than in its absence. However, albeit at a reduced rate, even Ccn2-null chondrocytes were still capable of proliferating and differentiating even with a drastically reduced intracellular ATP level. Here, we should note that the quantity of ATP we measured does not represent the total quantity that the cell actually produces and consumes. In the cells, ATP is continuously produced and readily used for any anabolic cellular activity. What we could measure was the ATP present in the cells. Interestingly, when we lowered the concentration of 17 FBS in the medium of Ccn2-null chondrocytes to an extremely low one, resulting in cellular dormancy, the quantity of intracellular ATP rose strikingly (data not shown).
Thus, even in the absence of CCN2, the chondrocytes were capable of producing the minimal energy to support their basic life functions.
Next, the mechanism by which CCN2 was supporting ATP synthesis was investigated.
The results of DNA microarray analysis showed that the lack of CCN2 during development resulted in increased expression of ribosomal protein genes and decreased that of several ECM and metabolism-associated genes. Of note, these genes included the ATP synthase subunit  gene, the product of which constructs the central shaft of the rotator of the mitochondrial molecular motor (von Ballmoos et al., 2009 ). The increase in ribosomal protein gene expression could be the outcome of the compensatory survival reaction under energy deficient conditions. Suspecting depressed mitochondrial activity in Ccn2-null chondrocytes, we next evaluated the mitochondrial membrane potential. However unexpectedly, no drastic difference in the membrane potential was observed between Ccn2-null and wild-type chondrocytes.
ATP production through oxidative phosphorylation in mitochondria is the major pathway for cells under normoxic conditions, whereas chondrocytes survive in an avascular microenvironment. Under such an environment, the significance of oxidative phosphorylation for the supply of energy would be expected to be relatively minor, with the anaerobic glycolytic pathway playing the major role in ATP production.
In fact in Fig. 2 , we showed that the levels of glycolytic metabolites in Ccn2-null chondrocytes were overall lower than those in the wild-type ones. Among these metabolites was phosphoenolpyruvate, formed from 2-phosphoglycerate by catalysis by enolase (Wold, 1971) . Enolase 1, commonly known as -enolase, is the major isozyme of enolases. Importantly, we found that its expression was significantly decreased in Ccn2-null chondrocytes, as determined by quantitative RNA analysis as well as by DNA microarray analysis. We already reported that CCN2 activated extracellular signal-regulated kinase 1/2 in chondrocytes in our previous study (Yosimichi et al., 2006) . Importantly, another previous study showed that, through this enolase gene, extracellular signal-regulated kinase 1/2 (ERK1/2) regulates intracellular ATP levels in cardiomyocytes during ischemic hypoxia and reoxygenation (Mizukami et al., 2004) . Therefore, CCN2 possibly regulates glycolysis via Eno1 expression through ERK1/2 signaling pathway in chondrocytes, which is, at least in part, responsible for the observed effects of CCN2 on cellular ATP level. However, the cell surface receptor that initiates this signaling is not defined yet. In addition, since CCN2 interacts a number of other growth factors, indirect effects mediated by such cofactors may not be overlooked. Further investigation to clarify the mechanism of the CCN action in detail is currently ongoing.
ATP is the most important molecule that mediates biological energy transfer for a variety of processes in living organisms. Therefore, a critical basal level of cellular ATP must be present at all times. In contrast, the CCN2 gene is known to be expressed at particular stages during the development of relevant organs . Moreover, Ccn2 expression is highly restricted to limited tissues in normal adults. These findings again indicate that CCN2 is not indispensable for basic energy metabolism, but is occasionally utilized when an enhanced energy supply is requested. The prominent induction of CCN2 observed upon wound healing is also consistent with this notion. In the growth plate, CCN2 is produced in large quantities only by chondrocytes in the pre-hypertrophic layer Takigawa, 2007, 2011) .
After being produced, CCN2 is transported and infiltrates in both directions in the growth plate, forming density gradients (Kawata et al., 2012) . On the resting side of the growth plate (upper portion in Fig. 8C ), chondrocytes located near the CCN2 producer receive strong CCN2 support that promotes their proliferation, whereas those farther away in the resting layer may not. On the hypertrophic side, ATP production enhanced by a vast number of CCN2 molecule is utilized for early hypertrophic differentiation with vigorous ECM production. CCN2 released in the bone marrow may also promote osteoblasts to proliferate and differentiate Safadi et al.,2003; Smerdel-Ramoya et al., 2008) and vascular endothelial cells to migrate (Shimo et al., 1998 and Babic et al., 1999) as well (Fig. 8C) .
Collectively, our results suggest that CCN2 plays an important role in endochondral ossification by enhancing ATP production where it is required.
From a pathogenic point of view, it should be also noted that ATP depletion could be considered as a causative factor for the development of osteoarthritis (OA; Johnson et al., 2004) . According to a recent report, impaired ATP production induced by glycolysis inhibitors promotes chondrocyte hypertrophy-like changes leading to the onset and development of OA-like lesions . Furthermore, the application of CCN2 to rat OA models induces the regeneration of damaged articular cartilage (Nishida et al., 2004) . Considering these findings together with our present results, the anti-OA action of CCN2 may be ascribed to the functional property of CCN2, i.e., prevention of the depletion of ATP. The utility of CCN2 in regenerative medicine for the treatment of cartilaginous tissues is again emphasized herein. 
